Marc Ferrante Selected Research

Marc Ferrante Research Topics

Disease

70	Crohn Disease (Crohn's Disease) 11/2022 - 12/2005
68	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 09/2006
59	Ulcerative Colitis 11/2022 - 06/2006
23	Necrosis 01/2022 - 09/2011
20	Inflammation (Inflammations) 01/2022 - 09/2006
12	Colitis 10/2021 - 02/2007
11	Neoplasms (Cancer) 01/2022 - 02/2014
8	Infections 01/2022 - 02/2014
6	Fistula 11/2022 - 02/2010
6	Pouchitis 01/2021 - 01/2008
5	Fibrosis (Cirrhosis) 01/2020 - 09/2008
4	Disease Progression 12/2020 - 10/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2016
3	Dysbiosis 01/2022 - 08/2014
3	Abdominal Pain (Pain, Abdominal) 01/2022 - 12/2013
2	Rheumatoid Arthritis 01/2022 - 02/2014
2	Hemorrhage 01/2022 - 01/2020
2	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 12/2021 - 10/2006
2	Cystic Fibrosis (Mucoviscidosis) 11/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 09/2019
2	Ulcer 12/2018 - 01/2014
2	Ileitis 10/2018 - 06/2008
2	Iron Deficiencies 01/2017 - 12/2007
1	Choristoma (Ectopic Tissue) 11/2022
1	Diarrhea 06/2022
1	Collagenous Colitis 06/2022
1	Fatigue 05/2022
1	Asymptomatic Diseases 12/2021

Drug/Important Bio-Agent (IBA)

41	Infliximab (Remicade)FDA Link 08/2022 - 03/2006
20	vedolizumabIBA 08/2022 - 09/2017
19	Pharmaceutical PreparationsIBA 01/2022 - 10/2013
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2008
14	AntibodiesIBA 12/2021 - 10/2007
13	Adalimumab (Humira)FDA Link 01/2022 - 11/2009
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2012
9	Biological ProductsIBA 08/2022 - 12/2009
9	Monoclonal AntibodiesIBA 12/2021 - 09/2008
8	SteroidsIBA 01/2022 - 06/2006
8	Immunologic Factors (Immunomodulators)IBA 10/2021 - 10/2013
7	golimumab FDA Link 01/2022 - 05/2016
7	Dextrans (Dextran)FDA Link 12/2020 - 01/2013
6	Ustekinumab (CNTO 1275)FDA Link 11/2022 - 07/2017
6	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2007
5	risankizumabIBA 01/2022 - 01/2017
5	SodiumIBA 12/2020 - 01/2013
5	CytokinesIBA 11/2019 - 01/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2010
4	Biosimilar PharmaceuticalsIBA 06/2020 - 01/2017
4	Tumor Necrosis Factor InhibitorsIBA 04/2018 - 01/2014
4	Phenobarbital (Luminal)FDA Link 02/2010 - 03/2006
3	CT-P13IBA 08/2022 - 01/2019
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	tofacitinibIBA 01/2022 - 05/2018
3	Janus Kinase InhibitorsIBA 01/2022 - 05/2018
3	Interleukin-12 (IL 12)IBA 07/2019 - 05/2018
3	IntegrinsIBA 01/2019 - 04/2018
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 07/2014
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 02/2014
3	PorinsIBA 06/2008 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 02/2014
2	mirikizumabIBA 01/2022 - 01/2020
2	InterleukinsIBA 01/2022 - 01/2019
2	ChloridesIBA 11/2021 - 10/2006
2	2-mercaptopurineIBA 01/2021 - 01/2020
2	AntigensIBA 09/2020 - 11/2007
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2020 - 12/2012
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2018
2	Drinking WaterIBA 01/2020 - 01/2018
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2020 - 11/2019
2	Interleukin-17 (Interleukin 17)IBA 11/2019 - 05/2018
2	Butyrates (Butyrate)IBA 09/2019 - 08/2014
2	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2014
2	Azathioprine (Imuran)FDA LinkGeneric 03/2019 - 08/2015
2	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 11/2007
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
2	IronIBA 01/2017 - 12/2007
2	Peptides (Polypeptides)IBA 01/2017 - 10/2007
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2006
2	Ferritins (Ferritin)IBA 01/2017 - 11/2005
2	ImmunosorbentsIBA 05/2016 - 07/2014
2	EnzymesIBA 05/2016 - 07/2014
2	LipocalinsIBA 12/2015 - 07/2014
2	Pattern Recognition ReceptorsIBA 06/2008 - 11/2007
2	Tranexamic Acid (AMCA)FDA Link 11/2007 - 10/2007
2	EpitopesIBA 11/2007 - 10/2007
1	Oncostatin MIBA 10/2021
1	SolutionsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021

Therapy/Procedure

69	Therapeutics 08/2022 - 11/2005
12	Biological Therapy 05/2022 - 12/2009
9	Restorative Proctocolectomy 06/2022 - 01/2008
7	Colectomy 10/2017 - 06/2006
1	Remission Induction 11/2022
1	Aftercare (After-Treatment) 11/2022
1	Bathroom Equipment 05/2022